As at March 14, 2025, there were 30,701,680 total voting common shares outstanding, which included 1,004,074 common
shares held by the trust and classified as treasury shares on our consolidated balance sheets (27,704,450 common shares, including 1,000,328 common shares classified as treasury shares at December 31, 2024). We had no non-voting common shares outstanding on any of the foregoing dates.
Convertible debentures
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 14, 2025 |
|
|
|
|
|
December 31, 2024 |
|
|
|
|
|
December 31, 2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.50% convertible debentures |
|
|
|
|
|
$ |
|
|
|
|
|
|
|
$ |
74,106 |
|
|
|
|
|
|
$ |
74,750 |
|
|
|
|
|
|
|
|
5.00% convertible debentures |
|
|
|
|
|
|
55,000 |
|
|
|
|
|
|
|
55,000 |
|
|
|
|
|
|
|
55,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
55,000 |
|
|
|
|
|
|
$ |
129,106 |
|
|
|
|
|
|
$ |
129,750 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The summarized terms of these convertible debentures are:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of issuance |
|
|
|
|
|
Maturity |
|
|
|
|
|
Conversion price |
|
|
|
|
|
Debt issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.50% convertible debentures |
|
|
|
|
|
|
June 1, 2021 |
|
|
|
|
|
|
|
June 30, 2028 |
|
|
|
|
|
|
$ |
24.23 |
|
|
|
|
|
|
$ |
3,531 |
|
|
|
|
|
|
|
|
|
|
5.00% convertible debentures |
|
|
|
|
|
|
March 20, 2019 |
|
|
|
|
|
|
|
March 31, 2026 |
|
|
|
|
|
|
$ |
25.29 |
|
|
|
|
|
|
$ |
2,691 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of December 31, 2024, our capital structure included two series of convertible unsecured subordinated debentures. The 5.50%
convertible debentures were issued on June 1, 2021, with an initial principal amount of $65.0 million, and an additional $9.8 million was issued on June 4, 2021, upon full exercise of the over-allotment option. Interest was
payable semi-annually on June 30 and December 31. These debentures were convertible into common shares at a specified price, subject to adjustment for events such as share consolidations, subdivisions, or reorganizations, and for dividends
exceeding $0.192 per share. They were redeemable on and after to June 30, 2024, and prior to June 30, 2026 at our option at the redemption price equal to the principal amount of the debentures plus accrued and unpaid interest thereon up to
but excluding the date set for redemption provided, among other things, the current market price was at least 125% of the conversion price on the date on which notice of the redemption is given. During the year ended December 31, 2024, a
principal amount of $0.6 million was converted into 26,576 common shares.
Subsequent to December 31, 2024, on January 29, 2025, we announced the full
redemption of our 5.50% convertible debentures due June 30, 2028, effective February 28, 2025. Holders were able to convert debentures into common shares at $24.23 per share until the redemption date. Any unconverted debentures were
redeemed for $1,008.86 per $1,000 principal, including accrued interest. The holders of the 5.50% convertible debentures elected to convert $72.7 million of the outstanding principal into 3,002,231 common shares. We paid the remaining balance of
$1.4 million in cash and delisted the debentures from the Toronto Stock Exchange. We also derecognized unamortized deferred financing costs of $1.9 million related to these debentures.
The 5.00% convertible debentures were issued on March 20, 2019, with a principal amount of $55.0 million. Interest is payable semi-annually on March 31
and September 30. These debentures are also convertible into common shares, with adjustments for similar events, and for dividends exceeding $0.12 per share. They are not redeemable by us except in connection with a change in control, under which
holders are entitled to require repurchase at 101% of the principal amount plus accrued interest.
The debentures are subject to protections for holders in the event
of reorganizations, such as mergers or amalgamations, ensuring equitable treatment.
Share purchase program
On November 4, 2024, we commenced a Normal Course Issuer Bid (NCIB) to purchase for cancellation up to 2,087,577 common shares. This amount represents
approximately 10% of the public float and 7.5% of the issued and outstanding common shares as of that date. To support the NCIB, we entered into an automatic share purchase plan with a designated broker on January 7, 2025. This plan allows for
the purchase of up to 2,087,577 common shares until the NCIBs expiry on November 3, 2025. During the year ended December 31, 2024, we purchased and
|
|
|
|
|
|
|
MANAGEMENTS DISCUSSION AND ANALYSIS |
|
31 |